InsidersTradesSigma
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (0 ops.)
Discover the full record of transactions filed by Coiante Scott M, Chief Financial Officer. Officer active across 1 companies, notably Aprea Therapeutics, Inc.. Cumulatively, 5 disclosures have been published. The latest transaction was disclosed on 3 June 2022 — Retenue fiscale. Regulator: SEC (Form 4). The full history is free.
Declarations5 total
€26,41935,284 shares@ €0.74880.44% mcap26.3% of flow
Common Stock
SEC:0001104659-22-069009:0·
042,900 shares0
Common Stock
SEC:0001104659-22-033391:0·
€23,03814,817 shares@ €1.55490.39% mcap22.9% of flow
Common Stock
SEC:0001104659-22-028760:0·
€25,4677,534 shares@ €3.3802100.0% of flow
Common Stock
SEC:0001104659-21-110596·
€25,4677,534 shares@ €3.38020.43% mcap25.4% of flow
Common Stock
SEC:0001104659-21-110596:0·
5 of 5 declarations
About Coiante Scott M
Scott M. Coiante is the Chief Financial Officer and Senior Vice President of Aprea Therapeutics, Inc. He is responsible for the financial management of the company, including budgeting, risk management, and financial reporting. His role is crucial in ensuring the financial health and sustainability of the organization.
